Table 1 Demographic and clinical characteristics of the 2 patient groups
| Â | All | Teriparatide-treated | Non-Teriparatide-treated | p-value |
|---|---|---|---|---|
Atypical fracture | 16 | 8 | 8 | Â |
Age (yr) | 70.15 | 70.25(68) | 69.25(72.5) | 0.916 |
Duration of Bisphosphonate use (yr) | 4.04 | 4.36 (5) | 4 (4) | 0.696 |
Proximal femur fracture | 6 | 3 | 3 | 1 |
Subtrochanteric fracture | 10 | 5 | 5 | 1 |
Time to union (month) | 5.3 | 4.4 (4) | 6.2 (5.6) | 0.093 |
Union at 6 months (%) | 10 (62.5%) | 6 (75%) | 4 (50%) | 0.608 |
Implant failure | 1 | 0 | 1 | 1 |